Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Attention deficit hyperactivity disorder
ADR ID BADD_A09509
ADR Hierarchy
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.04      Attention deficit and disruptive behaviour disorders
19.21.04.004      Attention deficit hyperactivity disorder
Description A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [MeSH]
MedDRA Code 10083622
MeSH ID D001289
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
ADD | ADDH | Attention deficit disorder | Attention deficit disorder of childhood | Attention deficit disorder of childhood with hyperactivity | Attention deficit disorder of childhood without mention of hyperactivity | Attention deficit-hyperactivity disorder | Attention deficit/hyperactivity disorder | Attention deficit/hyperactivity disorder NOS | Hyperactive child syndrome | Hyperkinesis of childhood with developmental delay | Hyperkinetic conduct disorder of childhood | Hyperkinetic syndrome | Hyperkinetic syndrome of childhood | Other specified manifestations of hyperkinetic syndrome of childhood | Overactive child | Syndrome hyperkinetic | Unspecified hyperkinetic syndrome of childhood | Hyperactivity syndrome aggravated | ADHD | ADHD, combined type | ADHD, predominantly hyperactive-impulsive type | ADHD, predominantly inattentive type | Attention deficit hyperactivity disorder | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorders with Hyperactivity | Attention Deficit Hyperactivity Disorders | Attention Deficit-Hyperactivity Disorder | Attention Deficit-Hyperactivity Disorders | Deficit-Hyperactivity Disorder, Attention | Deficit-Hyperactivity Disorders, Attention | Disorder, Attention Deficit-Hyperactivity | Disorders, Attention Deficit-Hyperactivity | Hyperkinetic Syndrome | Syndromes, Hyperkinetic | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention Deficit Disorders | Deficit Disorder, Attention | Deficit Disorders, Attention | Disorder, Attention Deficit | Disorders, Attention Deficit | Brain Dysfunction, Minimal | Dysfunction, Minimal Brain | Minimal Brain Dysfunction
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01547Nefazodone hydrochloride--
BADD_D01572Nitisinone0.012937%
BADD_D01617Ondansetron0.000043%
BADD_D01637Oxcarbazepine0.000460%
BADD_D01645Oxycodone0.000145%
BADD_D01679Paroxetine0.000472%
BADD_D01765Phenytoin0.000191%
BADD_D01834Prednisone0.000009%
BADD_D01888Quetiapine0.000185%
BADD_D01987Sapropterin0.046142%
BADD_D02010Sertraline0.000111%
BADD_D02047Sodium oxybate0.002441%
BADD_D02232Tobramycin0.000553%
BADD_D02247Topiramate0.000211%
BADD_D02326Valganciclovir--
BADD_D02329Valproic acid0.004443%
BADD_D02337Varenicline0.000818%
BADD_D02346Venlafaxine0.000048%
BADD_D02394Zolpidem0.000025%
BADD_D02440Lisdexamfetamine0.000800%
BADD_D02457Dexmethylphenidate0.001705%
BADD_D02464Fingolimod--
BADD_D02492Deflazacort0.000134%
The 2th Page    First    Pre   2    Total 2 Pages